Stockreport

Sangamo Therapeutics and Astellas Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases [Yahoo! Finance]

Sangamo Therapeutics, Inc.  (SGMO) 
Last sangamo therapeutics, inc. earnings: 2/28 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sangamo.com
PDF Sangamo Therapeutics and Astellas have entered into a license agreement that grants Astellas exclusive rights to use Sangamo's novel adeno-associated virus (AAV) capsid [Read more]